CVS, Express Scripts push for dismissal of US price-fixing claims over drugs
( October 16, 2025, 22:31 GMT | Official Statement) -- MLex Summary: CVS, Express Scripts, and OptumRx filed replies in support of their motions to dismiss antitrust claims over their negotiations with drug manufacturers. They argued that the remaining named plaintiff lacks standing because health plans bear much of the cost of medication purchases and the plaintiff offers no factual allegations showing that she paid any allegedly inflated cost.See attached. ...
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.